| Net loss | 112.41M |
| Depreciation and amortization | |
| (Increase) decrease in deferred income taxes | |
| Increase in unearned premiums | |
| Increase in deferred acquisition costs | |
| Realized gains on investments | |
| Amortization of loan origination costs | |
| Stock grant compensation expense | |
| Decrease in payable to related party | |
| Increase in income taxes payable | |
| Decrease in income taxes receivable | |
| Increase in premium and agent balances | |
| Decrease (increase) in reinsurance recoverables | |
| Increase in loss and loss adjustment expense reserves | |
| Changes in other operating assets and liabilities | |
| Net cash provided by operating activities | |
| Purchases of available-for-sale securities | -250.9M |
| Purchases of held-to-maturity securities | -175.78M |
| Proceeds from sales of available-for-sale securities | |
| Proceeds from maturities of available-for-sale securities | |
| Proceeds from maturities of held-to-maturity securities | 141.49M |
| Purchases of fixed assets | -31.12M |
| Net cash used in investing activities | |
| Payment of preferred dividends | |
| Net cash used in financing activities | |
| Net decrease in cash and cash equivalents | |
| Cash and cash equivalents, beginning of period | 669.45M |
| Cash and cash equivalents, end of period | 568.94M |
| Cash paid for interest | 42.4M |
| Dividends declared but unpaid | |